S. Verfaille

Safety, tolerability, pharmacokinetics, and effects on human experimental pain of the selective ionotropic glutamate receptor 5 (iGluR5) antagonist LY545694 in healthy volunteers

S. Iyengar, K. Petersen, W. R. Prucka, 2014, PAIN®.

Occupancy of Nociceptin/Orphanin FQ Peptide Receptors by the Antagonist LY2940094 in Rats and Healthy Human Subjects

Alan A. Wilson, M. Statnick, V. Barth, 2016, Drug Metabolism and Disposition.

Inositol as an add-on treatment for bipolar depression.

A. Vagnucci, A. Mallinger, A. Hardan, 2000, Bipolar disorders.

Direct neurectomy of the motor branches of the tibial nerve in hemiplegic adults: an assessment with a mean follow-up period of 11 years.

F. Beuret-Blanquart, P. Milliez, S. Demangeon, 2010, Annals of physical and rehabilitation medicine.

A proof-of-concept (POC) study including experimental pain models (EPMs) to assess the effects of a CB2 agonist (LY2828360) in the treatment of patients with osteoarthritic (OA) knee pain

L. Arendt-Nielsen, H. C. Hoeck, B. Boulanger, 2013 .

[Evaluation after four years of exercise therapy for chronic low back pain].

F. Beuret-Blanquart, S. Demangeon, S. Verfaille, 2005, Annales de Réadaptation et de Médecine Physique.